Pharmacists report being less confident in their knowledge of direct acting oral anticoagulants (DOACs) than of vitamin K antagonists, which may influence their ability to detect and manage complications arising from DOAC use. In a mystery shopper study, patient agents were sent into community pharmacies with symptom or product-related requests related to common complications that might arise during treatment with oral anticoagulants, with each visit being assessed for the preferred outcome. Only 10/41 (24.4%) visits resulted in the preferred outcome. A complete history-taking process, obtaining a medical history, patient characteristics and pharmacist involvement were strong predictors of the preferred outcome being achieved. The preferred...
cited By 2International audienceWhat is known and objective: The complex dose regimens of the direct...
AbstractDirect oral anticoagulants (DOACs) have been marketed in the United States since 2010. While...
What is known and objective: The complex dose regimens of the direct-acting oral anticoagulants (DO...
Pharmacists report being less confident in their knowledge of direct acting oral anticoagulants (DOA...
Introduction: Direct oral anticoagulants (DOACs) are common alternatives to warfarin. Contrary to ma...
Aim Direct oral anticoagulants (DOACs) are increasingly used compared to vitamin K antagonists (VKAs...
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introdu...
  Objective: Acenocoumarol is anoral anticoagulant with narrow therapeutic index, and the ideal do...
Service or Program: The Backus Hospital Medication Management Clinic located in Norwich, CT provides...
INTRODUCTION: Vitamin K antagonists are a class of drugs which are very commonly used in practice f...
Direct oral anticoagulants (DOACs) represent an innovation because they avoid periodic laboratory mo...
YesIntroduction: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expan...
BACKGROUND: The New Medicines Service (NMS) was implemented in the United Kingdom in 2011 and first ...
Background: Guidelines on the management of orally anticoagulated patients are continuously evolving...
AIMS: Even though the use of Direct Oral Anticoagulants (DOACs) is safe based on clinical outcomes, ...
cited By 2International audienceWhat is known and objective: The complex dose regimens of the direct...
AbstractDirect oral anticoagulants (DOACs) have been marketed in the United States since 2010. While...
What is known and objective: The complex dose regimens of the direct-acting oral anticoagulants (DO...
Pharmacists report being less confident in their knowledge of direct acting oral anticoagulants (DOA...
Introduction: Direct oral anticoagulants (DOACs) are common alternatives to warfarin. Contrary to ma...
Aim Direct oral anticoagulants (DOACs) are increasingly used compared to vitamin K antagonists (VKAs...
Abstract Introduction In the past decade, direct-acting oral anticoagulants (DOAC) have been introdu...
  Objective: Acenocoumarol is anoral anticoagulant with narrow therapeutic index, and the ideal do...
Service or Program: The Backus Hospital Medication Management Clinic located in Norwich, CT provides...
INTRODUCTION: Vitamin K antagonists are a class of drugs which are very commonly used in practice f...
Direct oral anticoagulants (DOACs) represent an innovation because they avoid periodic laboratory mo...
YesIntroduction: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expan...
BACKGROUND: The New Medicines Service (NMS) was implemented in the United Kingdom in 2011 and first ...
Background: Guidelines on the management of orally anticoagulated patients are continuously evolving...
AIMS: Even though the use of Direct Oral Anticoagulants (DOACs) is safe based on clinical outcomes, ...
cited By 2International audienceWhat is known and objective: The complex dose regimens of the direct...
AbstractDirect oral anticoagulants (DOACs) have been marketed in the United States since 2010. While...
What is known and objective: The complex dose regimens of the direct-acting oral anticoagulants (DO...